Report Detail
Global Equine Pharmaceuticals and Supplements Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4712501 |
- 29 June, 2026 |
- Global |
- 106 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Equine Pharmaceuticals and Supplements market size was valued at US$ 1341 million in 2025 and is forecast to a readjusted size of US$ 1806 million by 2032 with a CAGR of 4.4% during review period.
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.
This report is a detailed and comprehensive analysis for global Equine Pharmaceuticals and Supplements market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Equine Pharmaceuticals and Supplements market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Equine Pharmaceuticals and Supplements market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Equine Pharmaceuticals and Supplements market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Equine Pharmaceuticals and Supplements market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Equine Pharmaceuticals and Supplements
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Equine Pharmaceuticals and Supplements market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Equine Pharmaceuticals and Supplements market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pharmaceuticals
Supplements
Market segment by Application
Thoroughbred Horse
Other Types of Horses
Major players covered
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Pharmaceuticals and Supplements product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Pharmaceuticals and Supplements, with price, sales quantity, revenue, and global market share of Equine Pharmaceuticals and Supplements from 2021 to 2026.
Chapter 3, the Equine Pharmaceuticals and Supplements competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Pharmaceuticals and Supplements breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Equine Pharmaceuticals and Supplements market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Pharmaceuticals and Supplements.
Chapter 14 and 15, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Equine Pharmaceuticals and Supplements Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Pharmaceuticals
- 1.3.3 Supplements
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Equine Pharmaceuticals and Supplements Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Thoroughbred Horse
- 1.4.3 Other Types of Horses
- 1.5 Global Equine Pharmaceuticals and Supplements Market Size & Forecast
- 1.5.1 Global Equine Pharmaceuticals and Supplements Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Equine Pharmaceuticals and Supplements Sales Quantity (2021-2032)
- 1.5.3 Global Equine Pharmaceuticals and Supplements Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Boehringer Ingelheim
- 2.1.1 Boehringer Ingelheim Details
- 2.1.2 Boehringer Ingelheim Major Business
- 2.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
- 2.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Boehringer Ingelheim Recent Developments/Updates
- 2.2 Merck Animal Health
- 2.2.1 Merck Animal Health Details
- 2.2.2 Merck Animal Health Major Business
- 2.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
- 2.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Merck Animal Health Recent Developments/Updates
- 2.3 Zoetis
- 2.3.1 Zoetis Details
- 2.3.2 Zoetis Major Business
- 2.3.3 Zoetis Equine Pharmaceuticals and Supplements Product and Services
- 2.3.4 Zoetis Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Zoetis Recent Developments/Updates
- 2.4 Bayer Animal Health
- 2.4.1 Bayer Animal Health Details
- 2.4.2 Bayer Animal Health Major Business
- 2.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
- 2.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Bayer Animal Health Recent Developments/Updates
- 2.5 Elanco Animal Health
- 2.5.1 Elanco Animal Health Details
- 2.5.2 Elanco Animal Health Major Business
- 2.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
- 2.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Elanco Animal Health Recent Developments/Updates
- 2.6 Dechra Veterinary Products
- 2.6.1 Dechra Veterinary Products Details
- 2.6.2 Dechra Veterinary Products Major Business
- 2.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
- 2.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Dechra Veterinary Products Recent Developments/Updates
- 2.7 CEVA
- 2.7.1 CEVA Details
- 2.7.2 CEVA Major Business
- 2.7.3 CEVA Equine Pharmaceuticals and Supplements Product and Services
- 2.7.4 CEVA Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 CEVA Recent Developments/Updates
- 2.8 Virbac
- 2.8.1 Virbac Details
- 2.8.2 Virbac Major Business
- 2.8.3 Virbac Equine Pharmaceuticals and Supplements Product and Services
- 2.8.4 Virbac Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Virbac Recent Developments/Updates
- 2.9 Norbrook Equine
- 2.9.1 Norbrook Equine Details
- 2.9.2 Norbrook Equine Major Business
- 2.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
- 2.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Norbrook Equine Recent Developments/Updates
- 2.10 Kyoritsu Seiyaku
- 2.10.1 Kyoritsu Seiyaku Details
- 2.10.2 Kyoritsu Seiyaku Major Business
- 2.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
- 2.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Kyoritsu Seiyaku Recent Developments/Updates
- 2.11 Vetoquinol
- 2.11.1 Vetoquinol Details
- 2.11.2 Vetoquinol Major Business
- 2.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
- 2.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Vetoquinol Recent Developments/Updates
- 2.12 Protexin Healthcare
- 2.12.1 Protexin Healthcare Details
- 2.12.2 Protexin Healthcare Major Business
- 2.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
- 2.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Protexin Healthcare Recent Developments/Updates
- 2.13 Audevard
- 2.13.1 Audevard Details
- 2.13.2 Audevard Major Business
- 2.13.3 Audevard Equine Pharmaceuticals and Supplements Product and Services
- 2.13.4 Audevard Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Audevard Recent Developments/Updates
- 2.14 Ouro Fino Saude
- 2.14.1 Ouro Fino Saude Details
- 2.14.2 Ouro Fino Saude Major Business
- 2.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
- 2.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Ouro Fino Saude Recent Developments/Updates
3 Competitive Environment: Equine Pharmaceuticals and Supplements by Manufacturer
- 3.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2021-2026)
- 3.3 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Equine Pharmaceuticals and Supplements by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2025
- 3.4.3 Top 6 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2025
- 3.5 Equine Pharmaceuticals and Supplements Market: Overall Company Footprint Analysis
- 3.5.1 Equine Pharmaceuticals and Supplements Market: Region Footprint
- 3.5.2 Equine Pharmaceuticals and Supplements Market: Company Product Type Footprint
- 3.5.3 Equine Pharmaceuticals and Supplements Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Equine Pharmaceuticals and Supplements Market Size by Region
- 4.1.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Region (2021-2032)
- 4.1.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Region (2021-2032)
- 4.1.3 Global Equine Pharmaceuticals and Supplements Average Price by Region (2021-2032)
- 4.2 North America Equine Pharmaceuticals and Supplements Consumption Value (2021-2032)
- 4.3 Europe Equine Pharmaceuticals and Supplements Consumption Value (2021-2032)
- 4.4 Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value (2021-2032)
- 4.5 South America Equine Pharmaceuticals and Supplements Consumption Value (2021-2032)
- 4.6 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Type (2021-2032)
- 5.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Type (2021-2032)
- 5.3 Global Equine Pharmaceuticals and Supplements Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Application (2021-2032)
- 6.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Application (2021-2032)
- 6.3 Global Equine Pharmaceuticals and Supplements Average Price by Application (2021-2032)
7 North America
- 7.1 North America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2021-2032)
- 7.2 North America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2021-2032)
- 7.3 North America Equine Pharmaceuticals and Supplements Market Size by Country
- 7.3.1 North America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2021-2032)
- 7.3.2 North America Equine Pharmaceuticals and Supplements Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Equine Pharmaceuticals and Supplements Sales Quantity by Type (2021-2032)
- 8.2 Europe Equine Pharmaceuticals and Supplements Sales Quantity by Application (2021-2032)
- 8.3 Europe Equine Pharmaceuticals and Supplements Market Size by Country
- 8.3.1 Europe Equine Pharmaceuticals and Supplements Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Equine Pharmaceuticals and Supplements Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Region
- 9.3.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2021-2032)
- 10.2 South America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2021-2032)
- 10.3 South America Equine Pharmaceuticals and Supplements Market Size by Country
- 10.3.1 South America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2021-2032)
- 10.3.2 South America Equine Pharmaceuticals and Supplements Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size by Country
- 11.3.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Equine Pharmaceuticals and Supplements Market Drivers
- 12.2 Equine Pharmaceuticals and Supplements Market Restraints
- 12.3 Equine Pharmaceuticals and Supplements Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Equine Pharmaceuticals and Supplements and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Equine Pharmaceuticals and Supplements
- 13.3 Equine Pharmaceuticals and Supplements Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Equine Pharmaceuticals and Supplements Typical Distributors
- 14.3 Equine Pharmaceuticals and Supplements Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Equine Pharmaceuticals and Supplements. Industry analysis & Market Report on Equine Pharmaceuticals and Supplements is a syndicated market report, published as Global Equine Pharmaceuticals and Supplements Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Equine Pharmaceuticals and Supplements market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
